How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Micron Technology Inc. | €746.10 | €1,291.8 |
| Delta Air Lines Inc. | €73.57 | €72.95 |
| Aerovironment | €124.30 | €257.49 |
| Security | Price | Target price |
|---|---|---|
| Veganz Group AG | €2.53 | - |
| Jetblue Airways Corp. | €4.88 | €3.44 |
| Factset Research Systems | €225.50 | €188.94 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Veganz Group AG | AlexanderDanielSchneider | 22.82% |
| B Groupon Inc. | Traumtanz | 9.77% |
| B Quantum Corp. | Traumtanz | 9.26% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Veganz Group AG | blaugold | -36.43% |
| S Q32 Bio Inc. | thomasw | -25.28% |
| S Agenus Inc. | Wolf_of_WS | -21.09% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Krypto
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
UnitedHealth Group Inc.
WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Stock / Healthcare Providers & Services / Large Cap /
Pros
Cons
Coloplast A/S B
WKN: A1KAGC / Symbol: CLPBF / Name: Coloplast / Stock / Healthcare Equipment & Supplies / Large Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Travelers Companies | €322.60 | 8.870% |
| Seagate Technology.Holdings plc | €690.00 | 6.440% |
| Western Union Co. | €7.75 | 6.120% |
| Discovery Communications C | €22.42 | 5.110% |
| Coty Inc | €2.30 | 4.550% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Intuitive Surgical Inc | €301.80 | -14.190% |
| Cadence Design Systems | €288.55 | -9.660% |
| Synopsys Inc. | €336.00 | -7.810% |
| Netflix Inc. | €60.20 | -6.850% |
| Newell Rubbermaid | €4.58 | -6.090% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Key figures for stocks
Predictions
Top News
Cross Country Healthcare Clears Key Hurdle as Stockholders Approve Merger
Key Points
- Interested in Cross Country Healthcare, Inc.? Here are five stocks we like better.
- Cross Country Healthcare stockholders approved the company’s proposed merger agreement at a
Franklin Covey Showcases ‘Presenting for Impact’ to Turn Messages Into Action
Key Points
- Interested in Franklin Covey Company? Here are five stocks we like better.
- Franklin Covey highlighted its “Presenting for Impact” program in a webinar, positioning it as a framework
AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
Key Points
- Interested in AST SpaceMobile, Inc.? Here are five stocks we like better.
- AST SpaceMobile shares have fallen more than 18% in a week and nearly 60% since their May 28 all-time high
Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
Key Points
- Interested in Aehr Test Systems? Here are five stocks we like better.
- Aehr Test Systems shares jumped nearly 22% after the company beat earnings estimates and issued strong fiscal 2027
WaFd Q3 Earnings Call Highlights
Key Points
- Interested in WaFd, Inc.? Here are five stocks we like better.
- WaFd posted stronger fiscal Q3 earnings with net income of $62.5 million, or $0.84 per diluted share, up from $0.73 a
D-Wave Quantum Stock Slides 29% in July: Should You Buy the Dip?
The sharp pullback in D-Wave Quantum QBTS this month has shifted investor attention from the quantum computing sector's long-term promise to its near-term execution risks. After delivering
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
uniQure N.V. QURE now represents more than a single-program gene therapy story. Its profile is being reshaped by faster regulatory pathways, a narrower operating model and clinical work in rare
Realty Income Eyes Growth via Partnerships: Should You Buy or Hold?
Realty Income O is widening its growth playbook beyond buying properties with its balance sheet. The net-lease giant is building partnerships that bring in outside capital, open new sectors and
Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?
uniQure N.V. QURE has surged as investors reassessed AMT-130, its lead gene therapy candidate for Huntington's disease.
The question is whether the move already reflects too much optimism
News
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
Harmony Biosciences HRMY announced preliminary second-quarter 2026 results.
The company registered a record $261 million in net product revenues from its lead drug, Wakix (pitolisant).
Wakix
Can Novartis' Fabhalta Strengthen Its Nephrology Franchise?
Novartis NVS announced that the FDA has granted traditional approval to Fabhalta (iptacopan) for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at
HONA Growth Trends Ride Aerospace Demand and Aftermarket Shift
Honeywell Aerospace HONA has entered the market with exposure to several aerospace growth channels, from commercial aviation to defense and space. The stock’s long-term case depends on whether those
Reasons to Retain Doximity Stock in Your Portfolio for Now
Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence to expand beyond its core physician engagement platform. While robust physician adoption, growing
Is Honeywell Aerospace Stock Fairly Valued After Spinoff?
Honeywell Aerospace Inc. HONA enters the public market with scale, aerospace focus and a valuation that invites debate. The stock trades like a newly separated supplier with strong end-market
Honeywell Aerospace Stock Outlook After the Spin-Off Debut
Honeywell Aerospace Inc. HONA entered the public market with a business investors can evaluate more directly: a scaled aerospace supplier tied to commercial aviation, business aviation, defense and
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth
Intuitive Surgical, Inc. ISRG reported second-quarter 2026 adjusted earnings per share (EPS) of $2.80, which beat the Zacks Consensus Estimate of $2.48 by 12.9%. The bottom line increased 27.9% from
Can Investment Income Cushion Premium Pressure for RNR's Q2 Earnings?
RenaissanceRe Holdings Ltd. RNR is set to report second-quarter 2026 results on July 22, after the closing bell. The bottom-line estimate is currently pegged at $11.37 per share on revenues of $2.67
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.